Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen.

Source:http://linkedlifedata.com/resource/pubmed/id/10509041

Download in:

View as

General Info

PMID
10509041